Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78209


Purpose:

Primary: • To compare the safety profile of a single intravenous administration of AVP-21D9 as compared with Placebo Secondary: - To evaluate the pharmacokinetics (PK) of a single intravenous administration of AVP-21D9 - To evaluate the immunogenicity of AVP-21D9


Study summary:

This is a sequential, dose-escalating healthy volunteer study of the safety and pharmacokinetics of intravenously-infused AVP-21D9.


Criteria:

Key Inclusion Criteria: - Healthy volunteers, between 18 and 45 years of age - Normal laboratory (blood test) results Key Exclusion Criteria: - Prior immunization with anthrax vaccine


NCT ID:

NCT01202695


Primary Contact:

Study Director
Robert Hopkins, M.D.
Emergent BioSolutions


Backup Contact:

N/A


Location Contact:

San Antonio, Texas 78209
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.